Sio Gene Therapies Inc.
SIOX
Revenue
0.00
0.000.00%
-Assets
47.27M
▼-6.47M▼-12.05%
3 Months ChangeLiabilities
2.15M
▼-2.68M▼-55.48%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-04-06
Form 8-K
ID: 0001636050-23-000016
2023-03-15
Form 8-K
ID: 0001636050-23-000011
2023-02-14
Form 8-K
ID: 0001636050-23-000008
2023-02-14
Form 10-Q
ID: 0001636050-23-000007
2022-12-14
Form 8-K
ID: 0001636050-22-000054
2022-11-10
Form 8-K
ID: 0001636050-22-000051
2022-11-10
Form 10-Q
ID: 0001636050-22-000050
2022-09-14
Form 8-K
ID: 0001636050-22-000043
2022-08-11
Form 8-K
ID: 0001636050-22-000041
2022-08-11
Form 10-Q
ID: 0001636050-22-000040